IL142720A - Water-miscible pharmaceutical compositions of paclitaxel - Google Patents

Water-miscible pharmaceutical compositions of paclitaxel

Info

Publication number
IL142720A
IL142720A IL14272099A IL14272099A IL142720A IL 142720 A IL142720 A IL 142720A IL 14272099 A IL14272099 A IL 14272099A IL 14272099 A IL14272099 A IL 14272099A IL 142720 A IL142720 A IL 142720A
Authority
IL
Israel
Prior art keywords
paclitaxel
water
pharmaceutical compositions
miscible pharmaceutical
miscible
Prior art date
Application number
IL14272099A
Other languages
English (en)
Other versions
IL142720A0 (en
Original Assignee
Supergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supergen Inc filed Critical Supergen Inc
Publication of IL142720A0 publication Critical patent/IL142720A0/xx
Publication of IL142720A publication Critical patent/IL142720A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14272099A 1998-10-30 1999-09-22 Water-miscible pharmaceutical compositions of paclitaxel IL142720A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/183,199 US6017948A (en) 1998-10-30 1998-10-30 Water-miscible pharmaceutical compositions
PCT/US1999/021990 WO2000025775A1 (en) 1998-10-30 1999-09-22 Water-miscible pharmaceutical compositions of paclitaxel

Publications (2)

Publication Number Publication Date
IL142720A0 IL142720A0 (en) 2002-03-10
IL142720A true IL142720A (en) 2005-03-20

Family

ID=22671864

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14272099A IL142720A (en) 1998-10-30 1999-09-22 Water-miscible pharmaceutical compositions of paclitaxel

Country Status (11)

Country Link
US (1) US6017948A (de)
EP (1) EP1124549B1 (de)
JP (1) JP2002528494A (de)
CN (1) CN1178655C (de)
AT (1) ATE254455T1 (de)
AU (1) AU775158B2 (de)
CA (1) CA2345697A1 (de)
DE (1) DE69912983D1 (de)
IL (1) IL142720A (de)
MX (1) MXPA01004268A (de)
WO (1) WO2000025775A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
US6040330A (en) * 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
EP1418945A2 (de) * 2001-03-13 2004-05-19 Angiotech Pharmaceuticals, Inc. Mizellare arzneimittelabgabe vehikel und ihre anwendungen
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
JP2004532847A (ja) 2001-04-20 2004-10-28 ザ ユニヴァーシティ オヴ ブリティッシュ コロンビア 疎水性薬物のためのミセル薬物送達システム
US20030126788A1 (en) * 2001-11-07 2003-07-10 Colloid Tech. Inc. Storage stable translucent flammable article
WO2003047508A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Paclitaxel solvates
US6537985B1 (en) 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
PL206379B1 (pl) * 2002-07-15 2010-08-31 Alcon Ulegająca bioerozji kompozycja do wytwarzania błony do dostarczania leków oftalmicznych i zastosowanie
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
ZA200800314B (en) 2005-06-29 2009-09-30 Threshold Pharmaceuticals Inc Phosphoramidate alkylator prodrugs
US9943490B2 (en) * 2007-11-05 2018-04-17 The Trustees Of Princeton University Composite flash-precipitated nanoparticles
PL2231144T3 (pl) * 2007-12-24 2014-12-31 Sun Pharma Advanced Res Co Ltd Nanodyspersja
WO2010048330A1 (en) * 2008-10-21 2010-04-29 Threshold Pharmaceuticals, Inc. Treatment of cancer using hypoxia activated prodrugs
US8778364B2 (en) 2009-06-19 2014-07-15 Sun Pharma Advanced Research Company Ltd. Nanodispersion of a drug and process for its preparation
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
US20120172796A1 (en) * 2010-12-30 2012-07-05 Chappa Ralph A Composition for intravascular delivery of therapeutic composition
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN112972419B (zh) * 2019-12-02 2024-03-08 四川科伦药物研究院有限公司 一种白蛋白纳米药物组合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5034397A (en) * 1985-12-12 1991-07-23 Bristol-Myers Squibb Co. Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
US4772589A (en) * 1986-10-29 1988-09-20 Bristol-Myers Etoposide solution in NMP
JP2963537B2 (ja) * 1989-05-26 1999-10-18 アボツト・ラボラトリーズ クラリトロマイシンの注射用組成物
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE69507493T2 (de) * 1994-09-01 1999-06-10 Upjohn Co Tirilazad parentale formulierung mit einem co-lösungsmittel
AU4652596A (en) * 1995-01-09 1996-07-31 Atrix Laboratories, Inc. Liquid polymer delivery system
US5681846A (en) * 1995-03-17 1997-10-28 Board Of Regents, The University Of Texas System Extended stability formulations for paclitaxel
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
CZ293747B6 (cs) * 1995-12-21 2004-07-14 Pfizer Inc. Vodný farmaceutický roztok vhodný pro injekční podávání hostiteli a jeho použití
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US5877205A (en) * 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
US5922754A (en) * 1998-10-02 1999-07-13 Abbott Laboratories Pharmaceutical compositions containing paclitaxel

Also Published As

Publication number Publication date
MXPA01004268A (es) 2002-06-04
WO2000025775A1 (en) 2000-05-11
EP1124549B1 (de) 2003-11-19
IL142720A0 (en) 2002-03-10
AU6397799A (en) 2000-05-22
JP2002528494A (ja) 2002-09-03
AU775158B2 (en) 2004-07-22
ATE254455T1 (de) 2003-12-15
DE69912983D1 (de) 2003-12-24
CN1368880A (zh) 2002-09-11
EP1124549A1 (de) 2001-08-22
US6017948A (en) 2000-01-25
CA2345697A1 (en) 2000-05-11
CN1178655C (zh) 2004-12-08

Similar Documents

Publication Publication Date Title
IL142720A0 (en) Water-miscible pharmaceutical compositions of paclitaxel
AU2003247798A1 (en) Nozzles and components thereof and methods for making the same
WO2001087824A3 (en) 7-substituted fused ring tetracycline compounds
WO2003035617A3 (en) Derivatives of uk-2a
WO2001034835A3 (en) Method for the production of biopolymers with modified properties
AU2003285424A1 (en) Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
IL155263A0 (en) Pharmaceutical solutions of modafinil compounds
AU1915399A (en) Cs-1 peptidomimetics, compositions and methods of using the same
TWI256304B (en) Pharmaceutical compositions based on azetidine derivatives
AU5090899A (en) Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
BR0007922A (pt) Compostos calcilìticos
AU2001262606A1 (en) Semi-solid primer compositions
AU6339000A (en) Serotonergic benzothiophenes
AU4714297A (en) Metalloproteinase inhibitors
EP1082126A4 (de) Neue peptide
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
HK1051356A1 (zh) 钙溶性化合物
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU7124400A (en) Radiation-curable, cyanoacrylate-containing compositions
AU2002230579A1 (en) Calcilytic compounds
AU5176299A (en) Compound, composition and use
AU4847799A (en) High electron mobility transistor
WO1999061598A3 (en) Lentiviral vector compositions and methods of use
AU3880399A (en) Octahydropyrrolo-(3,4-c)carbazoles useful as analgesic agents
AU5054099A (en) Non-aqueous anthelmintic composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees